05/29/2026
Exciting news from Illume Wellbeing! We are proud to announce that we are now offering Spravato (esketamine) in addition to our established IV ketamine infusion therapy program. This means our patients have access to two evidence based ketamine treatment options, allowing us to create a more personalized treatment plan based on individual needs, goals, and insurance benefits. One of the advantages of Spravato is that it is FDA-approved and often covered by insurance for eligible patients, making advanced depression treatment more accessible for many individuals. If you’ve been struggling with depression, despite trying traditional medications, we invite you to learn whether IV ketamine or Spravato may be right for you.